Detection of polyomavirus bk reactivation after renal transplantation using an intensive decoy cell surveillance program is cost-effective
MetadataShow full item record
BACKGROUND.: Reactivation of polyomavirus BK (BKV) after renal transplantation can lead to allograft dysfunction or loss with early detection improving outcomes. Current guidelines recommend quantitative polymerase chain reaction for surveillance; however, urinary decoy cell detection is a potentially cost-effective alternative. We present the outcomes from an early intensive BKV surveillance program using decoy cell detection for initial screening starting 2 weeks after transplantation. METHODS.: Records for all recipients of kidney (n=211) or simultaneous kidney and pancreas (n=102) transplants performed over 2 years in a single center were reviewed. Follow-up was for a minimum of 1 year. Urine cytology screening was performed fortnightly from 0 to 3 months after transplantation, monthly from 3 to 6 months then every 2 months from 6 to 12 months. RESULTS.: Decoy cell positivity occurred in 56 of 313 patients (17.9%) with sustained decoy cell positivity (2 positive urine samples >2 weeks apart) present in 32 patients (10.2%). Twenty-four patients (7.6%) became viremic and three patients (1%) developed polyoma virus nephropathy. The median time after transplantation until decoy cell positivity was 78 days, decreasing to 67 days for patients with sustained positivity and 57 days for patients who developed polyoma virus nephropathy. No grafts were lost due to BKV during the study period. Decoy cell screening resulted in savings of approximately £135,000 over 2 years, when compared with routine surveillance by quantitative polymerase chain reaction. CONCLUSIONS.: Clinically significant BKV reactivation occurs early after transplantation and can be reliably detected by decoy cell screening. A surveillance strategy for detecting BKV reactivation based on urine cytology is cost-effective. Copyright © 2011 by Lippincott Williams & Wilkins.
Showing items related by title, author, creator and subject.
Konietzny, R.; Fischer, R.; Ternette, N.; Wright, C.; Turney, B.; Chakera, Aron; Hughes, D.; Kessler, B.; Pugh, C. (2012)Background: The diagnosis and management of BK virus (BKV) reactivation following renal transplantation continues to be a significant clinical problem. Following reactivation of latent virus, impaired cellular immunity ...
Cytomegalovirus viraemia and mortality in renal transplant recipients in the era of antiviral prophylaxis. Lessons from the western Australian experienceSelvey, Linda; Lim, W.; Boan, P.; Swaminathan, R.; Slimings, C.; Harrison, Amy; Chakera, A. (2017)Background: Cytomegalovirus (CMV) establishes a lifelong infection that is efficiently controlled by the immune system; this infection can be reactivated in case of immunosuppression such as following solid organ ...
Cost Effectiveness of Screening Patients With Gastroesophageal Reflux Disease for Barrett's Esophagus With a Minimally Invasive Cell Sampling DeviceHeberle, C.; Omidvari, A.; Ali, A.; Kroep, S.; Kong, C.; Inadomi, J.; Rubenstein, J.; Tramontano, A.; Dowling, E.; Hazelton, W.; Luebeck, E.; Lansdorp-Vogelaar, Iris; Hur, C. (2017)Background & Aims: It is important to identify patients with Barrett's esophagus (BE), the precursor to esophageal adenocarcinoma (EAC). Patients with BE usually are identified by endoscopy, which is expensive. The ...